Chemistry Alumnus Guadalupe Hayes-Mota Appointed to NIH Review Board
Hayes-Mota (SB '08) is the CEO of Healr Solutions, an MIT Senior Lecturer, and a Massachusetts Rare Disease Advisory Council Member.
Guadalupe Hayes-Mota (SB ’08, SM Engineering Systems ’16, MBA ’16), CEO of Healr Solutions, and MIT Senior Lecturer been appointed to the National Institute of Health (NIH) Cures Acceleration Network (CAN) Review Board by the US Secretary of Health and Human Services, Xavier Becerra.
CAN is a section of the Public Health Services Act that provides administrative powers, or a set of authorities. The National Center for Advancing Translational Sciences (NCATS) uses these authorities to advance the development of high-need cures and to address significant barriers between research discovery and clinical trials.
Hayes-Mota, who earned his bachelor’s degree from the Department of Chemistry in 2008, is an advocate and leader in healthcare, biotechnology, and public service. Among his many accolades is the Margaret L. A MacVicar Award, given in recognition of innovation, dedication and meaningful impact for the Alumni Association or the Institute. Last fall, he was named one of the PharmaVoice 100, a group of influential and devoted leaders lifting the pillars of the industry to new heights.
